JHP's cGMP compliance history was a critical factor in the selection process. Stuart Hinchen, CEO stated, "Our record of cGMP compliance, driven by experienced Quality and Regulatory Teams continues to be one of the key reasons customers choose JHP.
Additionally, both new and established customers recognize our approach to ongoing investment in people and facilities. As an example, last year we broke ground on a new $10 million, 40,000 sq. ft. laboratory that will house QC Chemistry and Method Transfer, Sterility Assurance and Stability. This type of investment allows us to focus on customer needs, which results in sustainable sales growth."
Hinchen noted, "Our use of disposable product contact equipment is another leading factor in the selection process. JHP's strategic use of disposables provides our customers with manufacturing process efficiencies that result in reduced cycle time."
JHP Pharmaceuticals' Rochester, Michigan facility has over 25 years' experience in contract manufacturing. Expertise in seamlessly progressing from clinical batch production to commercialization provides customers with continuity of supply and program efficiencies. A comprehensive suite of services including Regulatory, Analytical Methods Development, Package Engineering, Stability Testing and Validation also support contract manufacturing customers. JHP has successfully supported launches of several products in US and international markets and manufactures products for sale in 86 countries.
